Impact of the angiotensin II receptor AT 1 on the genesis of arterial hypertension and arteriosclerosis;Bedeutung des Angiotensin-II-Rezeptors AT 1 fur die Entstehung von arterieller Hypertonie und Arteriosklerose

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 33, 1997, Pages 1009-1013

  Nickenig, G ^a   Bohm M ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; MESSENGER RNA;

ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; SHORT SURVEY;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; RECEPTORS, ANGIOTENSIN;

EID: 0030806781     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Aguilera, G., K. Catt: Regulation of vascular angiotensin II receptors during altered sodium intake. Circ. Res. 49 (1981), 751-758.
2. Castelli, W. P., K. Anderson: A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham study. Amer. J. Med. 80, Suppl. 2 A (1986), 23-32.
3. Castelli, W. P., R. J. Garrison, P. W. F. Wilson, R. D. Abbot, S. Kalouscham, W. B. Kannel: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. J. Amer. med. Ass. 256 (1986), 2835-2838.
4. Chobanian, A. V., C. C. Haudenschild, C. Nickerson, S. Hope: Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension 20 (1992), 473-477.
5. Dzau, V.J., D. W. Burt, R. E. Pratt: Molecular biology of the reninangiotensin system. Amer. J. Physiol. 255 (1988), 563-573.
6. Griendling, K. K., B. Lassegue, T. J. Murphy, R. W. Alexander: Angiotensin II receptor pharmacology. Adv. Pharmacol. 28 (1994), 269-306.
7. Griendling, K. K., C. A. Minieri, J. D. Ollerenshaw, R. W. Alexander: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured smooth muscle cells. Circulat. Res. 74 (1994), 1141-1148.
8. Griendling, K. K., T. J. Murphy, R. W. Alexander: Molecular biology of the renin-angiotensin system. Circulation 87 (1993), 1816-1828.
9. 1receptor density changes during development of hypertension in hyperinsulinaemic rats. Clin. exp. Hypertens. 18 (1996), 793-810.
10. 1 receptor by transcriptional and posttranscriptional mechanisms. Evidence for homologous and heterologous regulation. Mol. Pharmacol. 48 (1995), 601-609.
11. 1 receptor. Gain-of-function study using gene transfer. Proc. nat. Acad. Sci. 92 (1995), 10663-10667.
12. Nickenig, G., A. Sachinidis, F. Michaelsen, M. Böhm, S. Seewald, H. Vetter: Up-regulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells. Circulation 95 (1997), 473-478.
13. Nickenig, G., T. J. Murphy: Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol. Pharmacol. 46 (1994), 653-659.
14. 1 receptor mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol. Pharmacol. 50 (1996), 743-751.
15. 1 Receptor expression. Amer. J. Physiol. (1997), in press.
16. Peach, M. J.: Renin-angiotensin system. Biochemistry and mechanism of action. Physiol. Rev. 57 (1977), 313-370.
17. Prichard, B. N. C., C. C. T. Smith, S. Sen, D. J. Betteridge: Hypertension and insulin resistance. J. cardiol. Pharmacol. 20 Suppl. 11 (1992), S77-S84.
18. Sowers, J. R.: Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy. Amer. Heart J. 122 (1991), 932-935.
19. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. clin. Invest. 95 (1995), 651-657.
20. Timmermans, P. B. M. W. M., P. C. Wong, A. T. Chiu, W. F. Herblin, P. Benfield, D. J. Carini, R. J. Lee, R. R. Wexler, J. A. M. Saye, R. D. Smith: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45 (1993), 205-251.
21. Yamada, T., M. Horiuchi, V. J. Dzau: Angiotensin II type 2 receptor mediates programmed cell death. Proc. nat. Acad. Sci. 93 (1996), 150-160.